# A Study of Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular Events

> **NCT07474649** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Daiichi Sankyo** · enrollment: 103 (estimated)

## Conditions studied

- Coronary Atherosclerosis
- Mixed Dyslipidemia
- Hypercholesterolemia

## Interventions

- **DRUG:** Bempedoic acid
- **DRUG:** Ezetimibe
- **DRUG:** Rosuvastatin
- **DRUG:** Atorvastatin

## Key facts

- **NCT ID:** NCT07474649
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2028-06-01
- **Final completion:** 2028-10-02
- **Target enrollment:** 103 (ESTIMATED)
- **Last updated:** 2026-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07474649

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07474649, "A Study of Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular Events". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07474649. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*